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ABSTRACT 
Ion channels regulate many aspects of 
cell physiology, including cell proliferation, 
motility, and migration, and aberrant expression 
and activity of ion channels is associated with 
various stages of tumor development, with K+ 
and Cl- channels now being considered the most 
active during tumorigenesis. Accordingly, 
emerging in vitro and preclinical studies have 
revealed that pharmacological manipulation of 
ion channel activity offers protection against 
several cancers. Merkel cell polyomavirus 
(MCPyV) is a major cause of Merkel cell 
carcinoma (MCC), primarily due to the 
expression of two early regulatory proteins 
termed small and large tumour antigens (ST and 
LT, respectively). Several molecular 
mechanisms have been attributed to MCPyV-
mediated cancer formation but thus far, no 
studies have investigated any potential link to 
cellular ion channels. Here we demonstrate that 
Cl- channel modulation can reduce MCPyV ST-
induced cell motility and invasiveness. 
Proteomic analysis revealed that MCPyV ST 
upregulates two Cl- channels; CLIC1 and CLIC4, 
which when silenced, inhibit MCPyV ST-
induced motility and invasiveness, implicating 
their function as critical to MCPyV-induced 
metastatic processes. Consistent with these data, 
we confirmed that CLIC1 and CLIC4 are 
upregulated in primary MCPyV-positive MCC 
patient samples. We therefore, for the first time, 
implicate cellular ion channels as a key host cell 
factor contributing to virus-mediated cellular 
transformation. Given the intense interest in ion 
channel modulating drugs for human disease, 
this highlights CLIC1 and CLIC4 activity as 
potential targets for MCPyV-induced MCC. 
 
 
During virus-induced transformation, 
alterations in the biological properties of infected 
cells by viral oncogenes confers properties that 
can drive tumour progression (1). The subversion 
of several host pathways have been linked to the 
oncogenic ability of viral proteins, but the 
modulation of host cell ion channel activity and 
the contribution of this important virus-host 
interaction to viral oncogenesis has not been 
studied. Ion channels regulate many aspects of 
cell physiology, including cell proliferation, 
motility and migration, making them an 
attractive target for viral manipulation (2,3). The 
aberrant expression and activity of ion channels 
is associated with various stages of tumour 
development, and emerging in vitro and 
preclinical studies have revealed that 
pharmacological manipulation of ion channel 
activity offers protection against several cancers 
(4). Merkel cell carcinoma (MCC) is a highly 
aggressive neuroendocrine carcinoma of the 
skin. MCC is characterized by the appearance of 
local or regional lymph nodes with a high 
propensity for distant metastases in various sites 
(5). Accordingly, MCC has a poor 5-year 
survival rate. The reported cases of MCC have 
tripled in the last 20 years in both Europe and the 
United states, due to an increase in associated 
risk factors, including UV exposure, 
immunosuppression and increased age (6).  
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In 2008, Merkel cell polyomavirus 
(MCPyV) was identified to be clonally integrated 
in ~80% of MCC tumours (7). Like other 
polyomaviruses, MCPyV expresses a variety of 
early spliced variant regulatory proteins required 
for viral replication and pathogenesis, including 
the small and large tumour antigens (ST and LT, 
respectively) (8). MCPyV infection and 
integration appear to occur prior to tumour cell 
expansion, with additional truncated LT 
mutations observed which render MCPyV 
replication defective (7). Notably, depletion 
studies have demonstrated that both ST and LT 
protein are required for MCC survival and 
proliferation (9). However, in contrast to other 
polyomaviruses, MCPyV ST is sufficient to 
transform rodent cells to anchorage- and contact-
independent growth and also induces serum-free 
proliferation of human cells (10). Recent studies 
have explored the contribution of MCPyV ST to 
MCC development and proliferation, suggesting 
it is highly multifunctional. MCPyV ST 
functions as an inhibitor of NF-ĸB-mediated 
transcription (11) and leads to the 
hyperphosphorylation of the translation 
regulatory protein, 4E-BP1, resulting in 
dyregulation of cap-dependent translation (10). It 
also promotes transcriptional changes in 
glycolytic metabolic pathways (12). Moreover, 
MCPyV ST prevents SCFFwb7-mediated 
degradation of MCPyV LT and several cellular 
oncoproteins (13). MCPyV ST also promotes 
differential expression of cellular proteins 
involved in microtubule and actin-associated 
cytoskeletal organization and dynamics, which 
leads to a motile and migratory phenotype 
(14,15). Notably, this MCPyV ST-induced 
migratory phenotype may be associated with the 
highly metastatic nature of MCC tumours. This 
is also supported by recent studies showing that 
engraftment of MCC cell lines into SCID mice 
results in circulating tumour cells and metastasis 
formation (16). 
We demonstrate herein that two 
members of the chloride channel family; a 
diverse group of anion selective channels, are 
upregulated by MCPyV ST to induce motility 
and invasiveness during MCPyV-induced 
metastasis.  This for the first time implicates 
cellular ion channels as a contributing factor to 
virus-mediated cellular transformation. 
 
RESULTS 
Cl- channel modulators inhibit MCPyV 
ST-induced cell motility - Viral proteins 
modulate cellular ion channel functionality to 
favour their lifecycles (2). In recent years, Cl- 
channels have emerged as some of the most 
active cellular ion channels during 
tumourigenesis, owing to their involvement in 
both cell motility and proliferation (17,18). We 
reasoned that Cl- channels could therefore play a 
role in MCPyV ST-induced cell motility. If so, 
Cl− channel blockers, including 
diisothiocyanostilbene-2,20-disulfonic acid 
(DIDS), 5-nitro-2-3-phenylpropylamino benzoic 
acid (NPPB) and indyanyloxyacetic acid 94 
(IAA-94) (3) would be predicted to 
affect  MCPyV ST-induced cell motility. This 
was investigated in two independent cell lines 
under conditions of MCPyV ST expression. 
i293-EGFP and i293-EGFP-ST cells were 
induced using doxycycline hyclate (14), while 
MCC13 cells (an MCPyV negative Merkel 
carcinoma cell line) were transfected with EGFP 
or EGFP-ST, and treated with each respective 
inhibitor for 24 h. Cell motility was assessed 
through IncuCyte imaging, every 30 min for 24 
h and the distance travelled by individual cells 
tracked using ImageJ. Figure 1A-B shows that 
MCPyV ST-expressing cells displayed larger 
average distances travelled (1.7 fold increase in 
motility in ST-expressing cells, n = 25, p<0.001) 
indicative of enhanced cell motility in both cell 
lines, consistent with previous findings (14). 
Figure 1A-B also demonstrates that, upon the 
addition of DIDS, NPPB and RIAA, no 
significant differences were observed between 
the average distances travelled by control GFP-
expressing cells, but the motility of MCPyV ST-
expressing cells significantly decreased 
following drug treatments in both cell types 
(reduced to baseline motility, n=25, p<0.001). 
The effects of the drugs were not-additive when 
combined, and validated as non-toxic at the 
concentrations assessed by MTS assay 
(Supplementary Figure 1). The effects of DIDS, 
NPPB and RIAA were reversible, as when the 
drugs were washed from the cells for 24 h, a 
significant recovery of cell motility was observed 
most notably in MCPyV-ST expressing MCC13 
cells (Figure 1A-B (iii), n = 25, p<0.001).  
To further confirm these effects, 
haptotaxis migration assays were performed in 
the presence of DIDS, NPPB and RIAA. This 
assay investigates the three-dimensional 
migration of cells towards a chemoattractant 
across a permeable chamber. Induced i293-
EGFP and i293-EGFP-ST cells were transferred 
to haptotaxis plates, and treated with DIDS, 
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NPPB and RIAA. Cells were allowed to migrate 
for 24 h and migration was assessed by 
immunofluorescent staining of cells that had 
migrated into the chambers. Figure 1C shows 
that i293-EGFP-ST cells displayed enhanced 
migration compared to control (n=3, p<0.001), 
which was significantly reduced by treatment 
with DIDS, NPPB and RIAA, suggesting that 
MCPyV ST-induced migration is similarly Cl- 
channel dependent. Together these data suggest 
that cellular Cl- channels are involved in MCPyV 
ST-induced cell motility and migration, and thus 
may contribute to MCPyV ST-induced 
metastatic processes. 
 
MCPyV ST enhances the expression of 
CLIC1 and CLIC4  - We next investigated the 
identity of the Cl− channel(s) required by 
MCPyV ST to enhance cell motility and 
migration. Approximately 40 genes encode 
proteins classified as Cl−intracellular-channel 
(CLIC) proteins, cyclic AMP-gated (CFTR)-, 
calcium-activated (CaCC)-, voltage-activated 
Cl− channels and Cl−/H+ exchangers (CLCs), as 
well as ligand-gated Cl− channels (GABA(A), 
GABA(C), and glycine) (19). We re-analysed 
our previous quantitative proteomic datasets to 
determine potential alterations in the host cell 
channelome upon inducible MCPyV ST 
expression (14). Analysis revealed that MCPyV 
ST expression upregulates the expression of two 
CLIC family proteins CLIC1 (Figure 2A, 5.67-
fold increase of ST/control cells) and CLIC4 
(Figure 2A, 4.39-fold increase of ST/control 
cells). To confirm these datasets, we assessed the 
levels of CLIC1 and CLIC4 expression upon 
MCPyV ST induction by immunoblotting cell 
lysates obtained from induced i293-EGFP and 
i293-EGFP-ST cells and MCC13 cells 
transfected with EGFP or EGFP-ST for 48 h. 
Figure 2B shows that both CLIC1 and CLIC4 
were upregulated upon MCPyV ST expression in 
both cell lines, confirming their upregulation 
(Figure 2B-C). This increase in CLIC1/CLIC4 
levels occurred at the protein level, as 
transcription levels assessed by RT-
qPCR remained relatively unchanged in both cell 
types (Figure 2D). The increase in expression 
was reflected by an increase in the cell surface 
expression of CLIC1 and CLIC4 in i293-EGFP-
ST cells compared to EGFP control, assessed 
using surface biotinylation assays (Figure 2E(i-
ii)). This was not a global effect on cell surface 
protein expression levels since the levels of 
transferrin receptor (CD71) were unaffected by 
MCPyV ST (Figure 2E(i-ii)). Together these data 
confirm that CLIC1 and CLIC4 are upregulated 
upon MCPyV ST expression. 
 
Depletion of CLIC1 and CLIC4 disrupts 
MCPyV ST-induced cell motility - Due to the 
increased expression of CLIC1 and CLIC4 in 
MCPyV ST-expressing cell lines, we 
investigated the effects of CLIC1/CLIC4 
silencing on MCPyV ST-induced cell motility. 
Induced i293-EGFP and i293-EGFP-ST cells or 
MCC13 cells transfected with EGFP or EGFP-
ST were transfected with CLIC1 and/or CLIC4-
specific siRNA. CLIC1/CLIC4 depletion both as 
single and double knockdowns was confirmed 
via immunblotting (Figure 3A(i) & 3B(i)). When 
the motility of MCPyV-ST-expressing i293 and 
MCC13 cells was assessed in CLIC1/CLIC4 
silenced cells (IncuCyte kinetic, cells imaged 
every 30 min for 24 h), significant decreases in 
the average distances travelled were observed 
compared to scrambled siRNA controls, most 
notably in MCPyV-ST MCC13 cells (return to 
baseline motility, n=25, p<0.001) (Figure 3A(ii) 
and 3B(ii)). Interestingly, differences in the 
average distance travelled for non-MCPyV-ST 
expressing cells following knockdown of CLIC1 
and/or CLIC4 were not observed suggesting they 
only contribute to the enhanced motility 
observed following MCPyV ST expression 
(Figure 3A-C, (n=25)). To confirm that the 
enhanced motility observed in MCPyV ST-
expressing cells is due to CLIC1/4 
overexpression we performed gain-of–function 
experiments to assess the effect of CLIC1 
overexpression in non-MCPyV ST expressing 
293 cells. Motility of EGFP-CLIC1-expressing 
cells (IncuCyte kinetic, cells imaged every 30 
min for 24 h) displayed a significant increase in 
cell motility over GFP control cells (Figure 4A, 
(n=25, p<0.001)) consistent with CLIC1 
induction leading to an enhanced motile 
phenotype. We also observed enhanced 
phosphorylation of ERK1/2 and NF-κB P65 
subunit following CLIC1 overexpression (Figure 
4B), the activation of which has been shown to 
enhance motility in a range of cancers (20,21). 
Activation of these signaling pathways may 
therefore contribute to the metastatic phenotype 
observed following CLIC1 overexpression.  
Furthermore, to demonstrate that the 
enhanced Cl− channel activity is required for cell 
motility and migration of MCPyV-positive MCC 
cell lines, haptotaxis migration assays were 
performed in the presence of NPPB at non-toxic 
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concentrations assessed by MTS assay 
(Supplementary Figure 2), or upon siRNA-
mediated CLIC1 depletion, using two MCPyV 
positive MCC cell lines. Cells were allowed to 
migrate for 24 h and migration was assessed by 
immunofluorescent staining of cells that had 
migrated into the chambers. Figure 4C shows 
that migration of MCPyV positive MCC cell 
lines were significantly reduced compared to 
control (n=3, p<0.001), upon treatment with 
either NPPB or CLIC1 depletion, suggesting that 
MCPyV positive MCC cell line migration is 
similarly Cl- channel dependent. Together these 
data demonstrate that the CLIC1 or CLIC4 
depletion specifically inhibits MCPyV ST-
induced motility, suggesting that these Cl- 
channels mediate the effects observed for 
pharmacological Cl- channel modulation.  
 
MCPyV-positive MCC tumours 
overexpress CLIC1 and CLIC4 - Finally, we 
assessed whether CLIC1 and CLIC4 are 
expressed and/or upregulated in MCC tumours. 
Immunoblot analysis was performed on cellular 
lysates of two independent MCPyV-positive 
MCC tumour samples (MCC#1 and #2) 
comparing protein levels against a negative non-
tumour cadaveric skin sample. Figure 5Ai and 
resulting densitometry analysis (Figure 5A(ii)) 
show that CLIC1 and CLIC4 expression is 
enhanced in both MCC samples compared to 
healthy skin. To further investigate the 
differential expression of CLIC proteins in the 
context of MCC, multicolour immunochemistry 
analysis was performed on formalin-fixed, 
paraffin-embedded (FFPE) sections of primary 
MCPyV-positive MCC tumours distinct from the 
tumour samples used above (MCC#3 and #4). 
Sections were incubated with antibodies specific 
for CLIC1 and cytokeratin 20 (CK20), a marker 
widely used to distinguish MCC and MCPyV LT 
(Figure 5B). An isotyped-matched control was 
also used as a negative control. Results 
confirmed increased levels of CLIC1 coincident 
with CK20 in regions of the tumour. 
Finally, to determine if CLIC1 and 
CLIC4 are significantly increased in MCPyV-
positive MCC compared with MCPyV-negative 
MCC, gene expression profiles for a total of 
ninety-four patients were obtained from a 
publicly available data-set (accession number 
GSE39612 (22)). Expression profiles were pre-
processed including background correction, 
normalisation and summation of the intensities 
for each sample using R/Bioconductor (23) and 
the R limma package used to call differentially 
expressed genes (24). Strikingly, we identified a 
significant increase in CLIC1 (2.5-fold, p=0.02) 
and CLIC4 (3.5-fold, p=0.002) in MCPyV-
positive MCC compared with MCPyV-negative 
MCC control samples. Moreover, CLIC1 
expression was also significantly increased (2.3-
fold, p=0.04) in metastatic MCPyV-positive 
MCC compared with a metastatic MCPyV-
negative MCC control, suggesting a link between 
MCC MCPyV-status and progression. 
Intriguingly, several other chloride ion channels 
from the CLIC and CLCN families were also 
dysregulated in a MCPyV-specific manner. 
Together, these data support our in vitro 
observations and suggest a link between 
MCPyV-mediated CLIC upregulation and MCC 
pathogenesis. Overall, these results confirm that 
CLIC1 and CLIC4 are upregulated during 
MCPyV infection in vivo, implicating a novel 
role for these channels in MCPyV-positive MCC 
tumourigenesis. 
 
DISCUSSION 
Growing evidence supports a role of 
cellular ion channels in cancer development, but 
somewhat surprisingly, their contribution to 
virus-induced cancer has yet to be documented. 
Cl- channels are considered one of the most 
active channel families during neoplastic 
transformation as they control ion homeostasis, 
pH levels, and cell volume, with the latter being 
particularly important for cancer cell migration 
and infiltration. We sought to assess the potential 
contribution of Cl- channels to the metastatic 
processes that occur during MCPyV infection. 
We show that MCPyV ST enhances the 
expression of CLIC1 and CLIC4, in transformed 
cell lines and primary MCC samples. When these 
channels are silenced or pharmacologically 
inhibited, MCPyV ST-induced motility is 
reduced. This, for the first time, identifies 
cellular Cl- channels that directly contribute to 
the metastatic processes of a viral oncogene.   
The dependence on CLIC1/CLIC4 
during MCPyV ST metastatic processes opens 
new insights into how viruses manipulate 
susceptible cells to mediate cancer progression. 
DNA viruses can encode viroporins (25); a group 
of viral ion channel proteins that participate in 
several viral functions, including the promotion 
of release of virus particles, modulation of 
cellular vesicles and membrane permeability. 
MCPyV has no known viroporin, suggesting it is 
likely that MCPyV proteins interfere with the 
MCPyV ST enhances Cl- channels for cell motility 
 
5 
 
normal channelome to benefit virus replication. 
The ability of MCPyV ST to specifically 
upregulate CLIC1/CLIC4 promotes metastatic 
activities in virus-infected cells. This is 
consistent with previous studies that identified 
the overexpression of CLIC1/CLIC4 in 
numerous cancer tissues including colon, 
prostate, pancreatic, and ovarian (26-28) 
suggesting they directly contribute to tumour 
development.  Interestingly, MCPyV-positive 
tumors were recently shown to display elevated 
expression of GABRB3 and K+ channel genes at 
the transcriptional level, which may play 
additional roles in the control of ionic balance 
during tumour growth (29). 
A key question remains, how does 
MCPyV ST target CLIC1 and CLIC4, and how 
does this ultimately benefit the virus? Both 
channels are widely expressed and their activity 
regulates components of the cytoskeleton, 
adhesion molecules, and cell signalling pathways 
(18,27,30), all of which may contribute to 
MCPyV ST tumour formation. We observed that 
the MCPyV ST effects on CLIC1/CLIC4 did not 
occur at the transcriptional level, ruling out the 
involvement of known MCPyV ST cellular 
targets including p53 and tumour necrosis factor 
α (TNFα) (31-33) that regulate CLIC transcript 
levels. Others have established that iNOS, 
through regulating channel nitrosylation can 
control the expression levels of CLICs through 
protein degradation (34). Though the ability of 
MCPyV ST to modulate iNOS has not been 
reported, it is currently under investigation. 
Moreover, it is not known whether the modified 
levels of CLIC1/CLIC4 mediate alterations in 
their intracellular activity in cellular organelles, 
as the analysis of channel functionality at these 
membranes is challenging. Thus, whilst it can be 
concluded that MCPyV ST-induced 
CLIC1/CLIC4 overexpression promotes a 
tumourigenic state, the mechanisms behind this 
regulation and their molecular contribution to 
MCC requires further investigation. It can be 
noted, however, that MCPyV ST most likely 
exploits CLIC1 and CLIC4 for a common 
cellular effect since simultaneous silencing of the 
channels resulted in no synergistic inhibition of 
MCPyV ST-induced cell motility. In addition, 
the observation that CLIC1 overexpression can 
activate ERK1/2 and NF-κB P65 raises the 
possibility that MCPyV ST targets 
CLIC1/CLIC4 to regulate the mitogenic 
signaling pathways that contribute to cancer 
metastasis (20,21). 
In conclusion, we reveal that MCPyV ST 
requires functional CLIC1 and CLIC4 channels 
to promote cell motility and invasion. To date, 
compounds specifically targeting CLIC1 and 
CLIC4 are not clinically available, and no 
CLIC1/CLIC4 blockers have advanced into 
clinical trials. However, with the emerging 
interest in this ion channel family as an anti-
cancer target, inhibiting these channels may 
emerge as a novel therapeutic approach for the 
treatment of MCC. 
 
EXPERIMENTAL PROCEDURES 
Mammalian cell culture - Inducible 
HEK-293-ST Flip-In cells, previously described 
(11,14), were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) containing 10% foetal 
bovine serum and 1% pen/strep. MCC13, 
WAGA (9) and PeTa (35) cells were maintained 
in RPMI 1640 media supplemented with 10% 
FBS and 1% pen/strep.  
Plasmids, siRNAs and Antibodies - 
EGFP-ST expression vectors have been 
previously described (11). EGFP-CLIC1 
expression construct was purchased from 
Origene. CLIC1 and CLIC4-specific siRNAs 
were purchased from Qiagen (Product number 
1027416). CLIC1 and CLIC4 antibodies were 
purchased from Santa Cruz Biotech (sc-81873) 
and Abcam (ab76593), respectively. Antibodies 
were used at 1:5000 dilution. The 2T2 hybridoma 
was provided by Dr Buck, National Cancer 
Institute, Bethesda, MD.  
Cl- channel modulators - RIAA (Sigma-
Aldrich), NPPB (Tocris Bioscience) and DIDS 
(Sigma-Aldrich) were used at the highest non-
toxic concentrations; 50, 25, and 50 μM for 
HEK-293 cells, and 100, 50, 100 μM for MCC13 
cells, respectively. 
Immunoblotting - Skin and MCC tumour 
biopsy samples were crushed using a pestle and 
mortar on dry ice, and homogenised by 
sonication prior to lysis in RIPA (50 mM Tris-
HCl pH 7.6, 150 mM NaCl, 1% NP40), 
supplemented with protease inhibitor cocktail 
(Roche) as previously described (36). Proteins 
were separated by SDS-PAGE, transferred to 
nitrocellulose membranes and probed with the 
appropriate primary and HRP-conjugated 
secondary antibodies as previously described 
(37).   
Live cell imaging - Cell motility was 
analysed using Incucyte kinetic live cell imaging 
(14). Imaging was performed for 24 h, with 
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images taken every 30 minutes. Cell motility was 
tracked using Image J software. 
Haptotaxis migration assay - Migration 
assays were performed using a CytoSelect 24-
well Haptotaxis Assay Collagen I coated plates 
(Cell Biolabs, Inc), as directed by the 
manufacturer. 
qRT-PCR - RNA was extracted using 
TRIzol (Invitrogen) and DNase treated as 
previously described (38). RNA concentration 
and quality was compared using a NanoDrop-
1000 spectrophotometer (NanoDrop 
Technologies) at 280nm. RNA (1μg) from each 
fraction was reverse transcribed with SuperScript 
II (Invitrogen) using oligo(dT) primers 
(Promega). mRNA quantitative analysis was 
performed using the comparative CT method as 
previously described (39). Primers used were as 
follows CLIC1 For: GAC ACC TTC CAT CTT 
CAG CAC T, CLIC1 Rev: CAA GAA TTC 
AAA CCC AGC ACT C, CLIC4 For: CAT CCG 
TTT TGA CTT CAC TGT TG, CLIC4 Rev: 
AGG AGT TGT ATT TAG TGT GAC GA. 
Cell viability assays - Cell viability was 
assessed 24 post-treatment using the CellTitre96 
AQueous OneSolution Cell Proliferation Assay 
reagent (Promega) as previously described (40). 
Multicolour immunohistochemistry - 
Formalin-fixed, paraffin-embedded (FFPE) 
sections from primary MCC tumours were 
procured from Origene and analysed as 
previously described (41).  Primary antibodies 
were: Anti-CK20 (Dako, dilution 1:50), Anti-
CLIC1 and CLIC-4 (Santa Cruz Biotech and 
Abcam, respectively, dilution 1:250) and Anti-
MCPyV LT (Santa Cruz Biotech, dilution 
1:100). An isotype-matched irrelevant antibody 
was used as a negative control on serial sections 
of tissues in parallel. 
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FIGURE LEGENDS 
 
FIGURE 1. Cl– channel blockers inhibit the metastatic phenotypic changes associated with ST 
expression. (A) i293-EGFP and i293-EGFP-ST cells were induced with doxycycline hyclate or (B) 
MCC13 cells were transfected with EGFP and EGFP-ST. (i)  Cells were then treated with DMSO, 
DIDS, RIAA, or NPPB and after 24 h, cell motility was measured using the IncuCyte kinetic imaging 
system. Images were taken every 30 min for a 24 h period. (ii) Scatter plot showing cell movement 
tracked using ImageJ (n = 25). Average cell movement, as indicated by the horizontal bar, was 
calculated and significance tested using a two-tailed Student’s t-test, * = p<0.001. (iii) After 24 h, 
inhibitors were washed off cells and media added. Cells were imaged for a further 24 h and average 
movement calculated (n = 25), * = p<0.001. (C) i293-EGFP and i293-EGFP-ST cells were induced and 
treated with DMSO, DIDS, RIAA, or NPPB. After 24 h, cells were transferred into migration wells and 
inhibitors added at appropriate concentrations to allow cells to migrate from serum-free to 10% FBS 
conditions for 24 h. Migratory cells were stained and measured at 560 nm to quantify migration. 
Average cell migration was calculated and significance tested using a two-tailed Student’s t-test (n = 
3), * = p<0.001.  
 
FIGURE 2. MCPyV ST upregulates CLIC proteins. (A) Quantitative proteomic analysis shows an 
increase in CLIC family protein levels upon MCPyV ST expression. (B) i293-EGFP or i293-EGFPST 
cells were incubated for 48 h in the presence of doxycycline, whereas MCC13 cells were transfected 
with EGFP or EGFP-ST for 24 h. Cell lysates were probed using CLIC1- and CLIC4-specific 
antibodies. GAPDH and β Actin were used to ensure equal loading. The 2T2 hybridoma was used to 
probe for MCPyV ST expression. (C) Densitometry was performed using ImageJ (n = 3) for (i) i293 or 
(ii) MCC13 samples, * = P<0.01. (D) Total RNA was extracted from induced i293-EGFP or i293-EGFP-
ST cells, reverse transcribed and RT-qPCR performed. Transcript levels were analysed using the 
comparative CT method (n = 3), * = P<0.01. (E) (i) Surface biotinylation experiments were performed 
in induced i293-EGFP or i293-EGFPST cells, lysates were probed for CLIC1, CLIC4 and CD71 as a 
surface marker control. (ii) Densitometry of Western blots was performed using ImageJ software (n = 
3), * = P<0.01. 
 
FIGURE 3. CLIC1 and CLIC4 KD inhibits MCPyV ST-induced cell motility.  (A) (i) i293-EGFP and 
i293-EGFP-ST cell lysates or (B) (i) EGFP or EGFP-ST-transfected MCC13 cells were probed for 
successful knockdown with CLIC1- and CLIC4-specific antibodies. GAPDH was used as loading 
control and 2T2 hybridoma was used to show MCPyV ST expression. (A) (ii) i293-EGFP and i293-
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EGFP-ST cells were transfected with scrambled or CLIC1 and/or CLIC4 siRNA for 12 h, then induced 
using doxycycline for 24 h. (B) (ii) MCC13 cells were transfected with scrambled or CLIC1 and/or 
CLIC4 siRNA for 12 h, then re-transfected with EGFP and EGFP-ST after a further 12 h. 48 h post-
knockdown, cell motility was measured using the IncuCyte kinetic imaging system. Images were taken 
every 30 min for a 24 h period. (C) Scatter plots showing cell movement of (i) i293 or (ii) MCC13 cells 
tracked using ImageJ (n = 25). Average cell movement, indicated by horizontal bar, was calculated and 
significance was tested using a two-tailed Student’s t-test, * = P<0.001.  
 
FIGURE 4. CLIC1 overexpression is required to induce cell motility in 293 and MCPyV positive MCC 
cell lines. (A) 293 cells were transfected with EGFP or EGFP-CLIC1 for 24 h. (i) Cell lysates were 
probed using CLIC1-specific antibody, GAPDH was used to ensure equal loading. (ii) Scatter plot 
showing cell movement tracked using ImageJ (n = 25). Average cell movement, as indicated by the 
horizontal bar, was calculated and significance tested using a two-tailed Student’s t-test, * = p<0.001. 
(B) 293 cells were transfected with EGFP or EGFP-CLIC1 for 24 h. Cell lysates were probed using 
CLIC1, ERK1/2 and NF-κB-specific antibodies, GAPDH was used to ensure equal loading. (C) 
MCPyV positive MCC cell lines, PeTa and WAGA, were (i) incubated with DMSO or NPPB or (ii) 
transfected with scrambled or CLIC1 siRNA for 12 h . Cells were then transferred into migration wells 
and allowed to migrate from serum-free to 10% FBS conditions for 24 h. Migratory cells were stained 
and measured at 560 nm to quantify migration. Average cell migration was calculated and significance 
tested using a two-tailed Student’s t-test (n = 3), * = p<0.001. (iii) PeTa and WAGA cells were probed 
to confirm successful knockdown with CLIC1-specific antibodies. GAPDH was used as loading 
control. 
 
FIGURE 5. CLIC1 and CLIC4 are upregulated in MCC.  (A) (i) Healthy skin and two independent 
MCC biopsy samples (MCC#1 and MCC#2) were crushed using a mortar and pestle on dry ice, lysed 
with RIPA buffer and then further homogenised by sonication. Tissue lysates were probed for CLIC1, 
CLIC4, GAPDH and 2T2. (ii) Densitometry of immunoblots was performed using ImageJ (n = 3), * = 
p<0.001. (B) Formalin-fixed, paraffin-embedded (FFPE) sections from primary MCC tumours 
(MCC#3 and MCC#4) were probed for (i) CK20 and CLIC1 and (ii) CK20 and MCPyV LT to 
demonstrate MCC sections were MCPyV positive. An isotype-matched antibody was used as a negative 
control in parallel. Nuclei were counterstained with DAPI. Representative images captured with a Zeiss 
LSM 510 confocal microscope are shown. 
 





